Flavonoids exert potential in the management of hypertensive disorders in pregnancy.


Journal

Pregnancy hypertension
ISSN: 2210-7797
Titre abrégé: Pregnancy Hypertens
Pays: Netherlands
ID NLM: 101552483

Informations de publication

Date de publication:
Aug 2022
Historique:
received: 06 06 2022
accepted: 29 06 2022
pubmed: 9 7 2022
medline: 10 8 2022
entrez: 8 7 2022
Statut: ppublish

Résumé

Hypertensive disorders in pregnancy represent severe complications of pregnancy, which, if not treated, can result in serious health consequences for the mother and the child. Flavonoids are bioactive secondary metabolites commonly found in fruits, vegetables, green tea, whole grains, and medicinal plants. Flavonoids exert potent protective efficacy in experimental models of hypertensive disorders in pregnancy, especially preeclampsia, demonstrated through their capacity to modulate inflammatory responses, oxidative stress, and vascular dysfunction. In addition to their potential as therapeutics, flavonoids or flavonoid-rich food could be helpful to decrease the risk of hypertensive disorders in pregnancy when included in the diet pattern before and during pregnancy. However, the clinical evaluation of the potential capacity of flavonoids in hypertensive disorders in pregnancy is insufficient. Due to promising results from experimental studies, we highlight the need for the evaluation of flavonoids also in an appropriate clinical setting, which can be, together with proper preventive strategies, helpful in the overall management of hypertensive disorders in pregnancy.

Identifiants

pubmed: 35803199
pii: S2210-7789(22)00064-2
doi: 10.1016/j.preghy.2022.06.007
pii:
doi:

Substances chimiques

Flavonoids 0
Tea 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

72-85

Informations de copyright

Copyright © 2022. Published by Elsevier B.V.

Auteurs

Alena Mazurakova (A)

Clinic of Obstetrics and Gynecology, Jessenius Faculty of Medicine, Comenius University in Bratislava, Martin, Slovakia.

Lenka Koklesova (L)

Clinic of Obstetrics and Gynecology, Jessenius Faculty of Medicine, Comenius University in Bratislava, Martin, Slovakia.

Marek Samec (M)

Department of Pathological Physiology, Jessenius Faculty of Medicine, Comenius University in Bratislava, Martin, Slovakia.

Erik Kudela (E)

Clinic of Obstetrics and Gynecology, Jessenius Faculty of Medicine, Comenius University in Bratislava, Martin, Slovakia.

Jana Sivakova (J)

Clinic of Obstetrics and Gynecology, Jessenius Faculty of Medicine, Comenius University in Bratislava, Martin, Slovakia.

Terezia Pribulova (T)

Clinic of Obstetrics and Gynecology, Jessenius Faculty of Medicine, Comenius University in Bratislava, Martin, Slovakia.

Martin Jozef Pec (MJ)

1st Department of Internal Diseases, University Hospital Martin and Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovakia.

Martin Pec (M)

Department of Medical Biology, Jessenius Faculty of Medicine, Comenius University in Bratislava, Martin, Slovakia.

Martin Kello (M)

Department of Pharmacology, Faculty of Medicine, Pavol Jozef Safarik University, Kosice, Slovakia.

Dietrich Büsselberg (D)

Department of Physiology and Biophysics, Weill Cornell Medicine-Qatar, Education City, Qatar Foundation, Doha, Qatar.

Olga Golubnitschaja (O)

European Association for Predictive, Preventive and Personalised Medicine, EPMA, Brussels, Belgium; Predictive, Preventive and Personalised (3P) Medicine, Department of Radiation Oncology, University Hospital Bonn, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany.

Ludovit Gaspar (L)

Faculty of Health Sciences, University of Ss. Cyril and Methodius in Trnava, Trnava, Slovakia.

Martin Caprnda (M)

1(st) Department of Internal Medicine, Faculty of Medicine, Comenius University and University Hospital, Bratislava, Slovakia.

Mariusz Adamek (M)

Department of Thoracic Surgery, Medical University of Silesia, Katowice, Poland.

Robert Prosecky (R)

International Clinical Research Centre, Masaryk University and St. Annés University Hospital, Brno, Czech Republic; 2(nd) Department of Internal Medicine, Faculty of Medicine, Masaryk University and St. Annés University Hospital, Brno, Czech Republic.

Elmira Eminova (E)

International Research Centre "Biotechnologies of the Third Millennium", Faculty of Biotechnologies (BioTech), ITMO University, Saint-Petersburg, Russian Federation.

Denis Baranenko (D)

International Research Centre "Biotechnologies of the Third Millennium", Faculty of Biotechnologies (BioTech), ITMO University, Saint-Petersburg, Russian Federation.

Peter Kruzliak (P)

2(nd) Department of Surgery, Faculty of Medicine, Masaryk University and St. Annés University Hospital, Brno, Czech Republic. Electronic address: peter.kruzliak@fnusa.cz.

Peter Kubatka (P)

Department of Medical Biology, Jessenius Faculty of Medicine, Comenius University in Bratislava, Martin, Slovakia. Electronic address: peter.kubatka@uniba.sk.

Kamil Biringer (K)

Clinic of Obstetrics and Gynecology, Jessenius Faculty of Medicine, Comenius University in Bratislava, Martin, Slovakia. Electronic address: kamil.biringer@uniba.sk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH